Showing results (91-100 of 106) with videos related to
Sort By:
Pageof 11
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1986
Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effectsH Depoortere, B Zivkovic, K G Lloyd, et al.Pharmacopsychiatry|May 1, 1990
Selectivity for omega-receptor subtypes as a strategy for the development of anxiolytic drugsS Z Langer, S Arbilla, S Tan, et al.Brain Research|October 13, 1987
Effects of the GABA receptor agonist, progabide, upon local cerebral glucose utilizationA Cudennec, D Duverger, K G Lloyd, et al.Environmental Science & Technology|June 16, 2023
Identifying and Understanding Microbial Methanogenesis in CO2 StorageR L Tyne, P H Barry, M Lawson, et al.Journal of Medicinal Chemistry|March 1, 1989
3-aminopyridazine derivatives with atypical antidepressant, serotonergic, and dopaminergic activitiesC G Wermuth, G Schlewer, J J Bourguignon, et al.The Journal of Pharmacology and Experimental Therapeutics|March 1, 1982
gamma-Aminobutyric acid (GABA) receptor stimulation. II. Specificity of progabide (SL 76002) and SL 75102 for the GABA receptorK G Lloyd, S Arbilla, K Beaumont, et al.European Journal of Pharmacology|July 18, 1989
Pharmacological characterization of the aminopyridazine SR 95639A, a selective M1 muscarinic agonistC Schumacher, R Steinberg, J P Kan, et al.Annals of Neurology|December 1, 1979
Familial fatal Parkinsonism with alveolar hypoventilation and mental depressionA Purdy, A Hahn, H J Barnett, et al.The Journal of Pharmacology and Experimental Therapeutics|April 1, 1987
Fengabine, a novel antidepressant GABAergic agent. II. Effect on cerebral noradrenergic, serotonergic and GABAergic transmission in the ratB Scatton, K G Lloyd, B Zivkovic, et al.Pharmacology, Biochemistry, and Behavior|October 1, 1985
Non-benzodiazepine anxiolytics: potential activity of phenylpiperazines without 3H-diazepam displacing actionK G Lloyd, H Depoortere, B Scatton, et al.Pageof 11